HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia
Frédéric Baron(University of Liège), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David G. Maloney(Fred Hutch Cancer Center), Monic J. Stuart(United States Department of Veterans Affairs), Thomas R. Chauncey(City Of Hope National Medical Center), Barry E. Storer(City Of Hope National Medical Center), Brenda M. Sandmaier(University of Washington), Jerald P. Radich(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Edward Agura(Baylor University), Michael A. Pulsipher(Primary Children's Hospital), Michael B. Maris(Colorado Blood Cancer Institute), Judith A. Shizuru(Stanford University)
Cited by 49
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k